Loading...
Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients
OBJECTIVES: Cytomegalovirus (CMV) infection is responsible for significant morbidity and mortality among solid organ transplant recipients. Prophylaxis using valganciclovir (VGCV) in orthotopic liver transplant (OLT) recipients is not approved by the Food and Drug Administration and its use is contr...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Blackwell Publishing Ltd
2010
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3003475/ https://ncbi.nlm.nih.gov/pubmed/21083790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1477-2574.2010.00226.x |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|